INHIBITION BY 5-HT OF FORSKOLIN-INDUCED CAMP FORMATION IN THE RENAL OPOSSUM EPITHELIAL-CELL LINE OK - MEDIATION OF A 5-HT1B LIKE RECEPTOR AND ANTAGONISM BY METHIOTHEPIN

被引:25
作者
PAUWELS, PJ
PALMIER, C
机构
[1] Laboratory of Cellular Neurobiology, Centre de Recherche Pierre Fahre, 81106 CastresCédex
关键词
5-HYDROXYTRYPTAMINE RECEPTOR AGONISTS/ANTAGONISTS; BETA-ADRENERGIC RECEPTOR ANTAGONISTS; ADENYLATE CYCLASE; RENAL OK CELLS; 5-HT;
D O I
10.1016/0028-3908(94)90098-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The functional activity of various 5-HT receptor agonists, including 5-CT, sumatriptan, CP 93, 129 and 1-naphtylpiperazine, and of drugs known to bind with high affinity to 5-HT1B (pindolol, propranolol, cyanopindolol, SDZ 21,009 and isamoltane) or 5-HT1D binding sites (yohimbine and rauwolscine) was measured at 5-HT receptors that are negatively coupled to adenylate cyclase in cultures of the renal epithelial cell line OK. 5-HT receptor-mediated inhibition of adenylate cyclase was studied by measuring inhibition of cAMP formation, induced by 100 mu M forskolin. Besides 5-HT, various other compounds with affinity for 5-HT receptors behaved as agonists with the following rank order of potency: RU 24,969 > 5-CT > dihydroergotamine = 5-HT > CP 93,129 > d-LSD > 1-naphtylpiperazine > sumatriptan > TFMPP = mCPP > CGS 12066B = metergoline > methysergide. The beta-adrenergic receptor blockers cyanopindolol, SDZ 21,009 (-)-pindolol and (-)-propranolol, and the alpha(2)-adrenergic blockers yohimbine and rauwolscine yielded agonist. Methiothepin was the only compound that antagonised the OK cell 5-HT receptor has properties consistent with a 5-HT1B receptor, although differences are apparent with regard to potencies of some compounds. Methiothepin is probably the only effective antagonist at 5-HT1B receptor sites, whereas the described putative 5-HT1B receptor antagonists have to be considered as partial agonists, yielding agonist or antagonist activity depending on the system that is studied.
引用
收藏
页码:67 / 75
页数:9
相关论文
共 33 条
[1]  
ADHAM N, 1992, MOL PHARMACOL, V41, P1
[2]  
ADHAM N, 1993, MOL PHARMACOL, V43, P427
[3]   CLONING OF ANOTHER HUMAN SEROTONIN RECEPTOR (5-HT1F) - A 5TH 5-HT1 RECEPTOR SUBTYPE COUPLED TO THE INHIBITION OF ADENYLATE-CYCLASE [J].
ADHAM, N ;
KAO, HT ;
SCHECHTER, LE ;
BARD, J ;
OLSEN, M ;
URQUHART, D ;
DURKIN, M ;
HARTIG, PR ;
WEINSHANK, RL ;
BRANCHEK, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :408-412
[4]  
BODDEKE HW, 1992, N-S ARCH PHARMACOL, V345, P357
[5]   5-HT1B RECEPTORS ARE NEGATIVELY COUPLED WITH ADENYLATE-CYCLASE IN RAT SUBSTANTIA NIGRA [J].
BOUHELAL, R ;
SMOUNYA, L ;
BOCKAERT, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (02) :189-196
[6]   IDENTITY OF INHIBITORY PRESYNAPTIC 5-HYDROXYTRYPTAMINE (5-HT) AUTORECEPTORS IN THE RAT-BRAIN CORTEX WITH 5-HT1B BINDING-SITES [J].
ENGEL, G ;
GOTHERT, M ;
HOYER, D ;
SCHLICKER, E ;
HILLENBRAND, K .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 332 (01) :1-7
[7]  
FARGIN A, 1989, J BIOL CHEM, V264, P14848
[8]  
FRAZER A, 1990, ANNU REV PHARMACOL, V30, P307
[9]  
HAMBLIN MW, 1991, MOL PHARMACOL, V40, P143
[10]  
HAMON M, 1991, CARDIOVASCULAR PHARM, P41